NEW YORK, March 23, 2018 -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Seamus Fernandez will join the firm in June as a Senior Analyst and Senior Managing Director in a planned expansion of the firm’s Healthcare Research team. He will focus on companies in the pharmaceuticals industry globally and coordinate the firm’s research coverage of therapeutics.
Mr. Fernandez joins Guggenheim from LEERINK Partners, where he spent more than 10 years and served as a Managing Director covering major pharmaceutical and biotechnology companies, as well as specialty pharmaceuticals. Previous to joining LEERINK in 2006, he was a member of the Pharmaceuticals team at Cowen and Company’s Research Division. Mr. Fernandez began his career as a Research Associate at the University of Pennsylvania’s Department of Neurosurgery.
“We are excited for Seamus to join our Healthcare Research team,” said Stefano Natella, Director of Equity Research. “His deep industry knowledge, his ability to focus on the long-term issues driving this sector, and his differentiated approach to research will be key assets for our expanding research department. We look forward to his continued success at Guggenheim.”
Mr. Fernandez received his B.A. in Chemistry from Williams College.
About Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, Los Angeles, San Francisco, and Houston. For more information, please contact us at [email protected] or 212.518.9200.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $305 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1Assets under management are as of 12.31.2017 and include consulting services for clients whose assets are valued at approximately $66bn.
Media Contact
Ellen Cunningham
Guggenheim Partners
212.518.9578
[email protected]


Apple Restores Telegram to App Store After Content Policy Violation
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Jetstar to Charge for Overhead Cabin Bags From February
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 



